NCT00457561View on ClinicalTrials.gov

Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis

CompletedOBSERVATIONAL

Timeline

Start Date

Not specified

Conditions

Hemodialysis

All Listed Sponsors

lead

Hamamatsu University

OTHER

NCT00457561 - Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis | Biotech Hunter | Biotech Hunter